PortfoliosLab logo
Medifast, Inc. (MED)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US58470H1014

CUSIP

58470H101

IPO Date

Dec 31, 1993

Highlights

Market Cap

$144.20M

EPS (TTM)

-$0.64

PEG Ratio

1.95

Total Revenue (TTM)

$543.45M

Gross Profit (TTM)

$401.58M

EBITDA (TTM)

$6.40M

Year Range

$11.57 - $26.85

Target Price

$15.00

Short %

16.53%

Short Ratio

4.97

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Medifast, Inc. (MED) returned -25.54% year-to-date (YTD) and -47.50% over the past 12 months. Over the past 10 years, MED returned -6.15% annually, underperforming the S&P 500 benchmark at 10.69%.


MED

YTD

-25.54%

1M

3.23%

6M

-32.48%

1Y

-47.50%

5Y*

-29.95%

10Y*

-6.15%

^GSPC (Benchmark)

YTD

-0.64%

1M

8.97%

6M

-2.62%

1Y

11.90%

5Y*

15.76%

10Y*

10.69%

*Annualized

Monthly Returns

The table below presents the monthly returns of MED, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-10.90%-8.54%-6.13%-2.52%-0.15%-25.54%
2024-18.70%-26.64%-4.42%-28.16%-6.50%-15.23%0.50%-16.55%4.59%-3.97%7.02%-10.42%-73.79%
2023-3.38%0.61%-5.95%-11.59%-14.13%19.33%10.56%-17.22%-9.41%-7.60%-4.02%1.27%-38.34%
2022-5.12%-6.40%-7.29%4.44%-6.51%9.20%-6.83%-25.39%-12.44%7.96%7.74%-7.19%-42.31%
202119.52%7.81%-15.74%7.21%46.31%-14.37%0.89%-20.18%-14.92%1.88%4.83%2.48%9.36%
2020-11.82%-13.99%-23.47%21.41%34.87%36.77%20.44%-2.64%1.73%-14.57%45.31%-3.28%86.18%
20191.78%0.15%0.68%15.01%-12.09%0.09%-12.98%-10.47%4.41%7.05%-20.76%25.97%-9.73%
2018-1.58%-7.16%47.29%7.42%45.94%9.67%7.19%33.24%-2.92%-4.45%-29.85%-15.31%82.11%
20171.30%6.33%-0.32%4.39%-10.17%0.43%2.94%32.63%5.44%5.10%9.82%2.55%72.33%
2016-4.44%4.55%0.36%4.44%1.21%5.07%5.86%4.40%3.46%8.65%-4.82%7.33%41.31%
2015-5.54%-0.16%-5.28%0.10%7.30%0.40%-4.49%-10.04%-3.28%4.13%8.40%1.02%-8.71%
20141.53%-0.72%10.44%8.80%-0.69%-3.25%-5.59%17.03%-2.29%-3.32%-7.06%13.73%28.40%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MED is 8, meaning it’s performing worse than 92% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of MED is 88
Overall Rank
The Sharpe Ratio Rank of MED is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of MED is 44
Sortino Ratio Rank
The Omega Ratio Rank of MED is 77
Omega Ratio Rank
The Calmar Ratio Rank of MED is 1818
Calmar Ratio Rank
The Martin Ratio Rank of MED is 1010
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Medifast, Inc. (MED) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Medifast, Inc. Sharpe ratios as of May 13, 2025 (values are recalculated daily):

  • 1-Year: -1.07
  • 5-Year: -0.64
  • 10-Year: -0.13
  • All Time: 0.03

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Medifast, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History

Medifast, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%2.00%4.00%6.00%8.00%$0.00$1.00$2.00$3.00$4.00$5.00$6.00$7.002015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM2024202320222021202020192018201720162015
Dividend$0.00$0.00$4.95$6.56$5.68$4.52$3.38$2.19$1.44$1.07$0.25

Dividend yield

0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%

Monthly Dividends

The table displays the monthly dividend distributions for Medifast, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$1.65$0.00$0.00$1.65$0.00$0.00$1.65$0.00$0.00$0.00$4.95
2022$0.00$0.00$1.64$0.00$0.00$1.64$0.00$0.00$1.64$0.00$0.00$1.64$6.56
2021$0.00$0.00$1.42$0.00$0.00$1.42$0.00$0.00$1.42$0.00$0.00$1.42$5.68
2020$0.00$0.00$1.13$0.00$0.00$1.13$0.00$0.00$1.13$0.00$0.00$1.13$4.52
2019$0.00$0.00$0.75$0.00$0.00$0.75$0.00$0.00$0.75$0.00$0.00$1.13$3.38
2018$0.00$0.00$0.48$0.00$0.00$0.48$0.00$0.00$0.48$0.00$0.00$0.75$2.19
2017$0.00$0.00$0.32$0.00$0.00$0.32$0.00$0.00$0.32$0.00$0.00$0.48$1.44
2016$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.32$1.07
2015$0.25$0.25

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Medifast, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Medifast, Inc. was 98.33%, occurring on Dec 23, 1999. Recovery took 755 trading sessions.

The current Medifast, Inc. drawdown is 95.54%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.33%Feb 9, 19941483Dec 23, 1999755Dec 27, 20022238
-95.95%Jun 1, 2021976Apr 17, 2025
-85.56%Nov 7, 2003330Mar 2, 2005316Jun 2, 2006646
-83.16%Jun 22, 2006611Nov 21, 2008204Sep 16, 2009815
-78.91%Sep 13, 2018380Mar 18, 2020215Jan 25, 2021595

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Medifast, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Medifast, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 100.0% positive surprise.


0.001.002.003.004.00202120222023202420250
-0.07
Actual
Estimate

Valuation

The Valuation section provides an overview of how Medifast, Inc. is priced in the market compared to other companies in the Personal Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for MED compared to other companies in the Personal Services industry. MED currently has a PEG ratio of 2.0. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for MED relative to other companies in the Personal Services industry. Currently, MED has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for MED in comparison with other companies in the Personal Services industry. Currently, MED has a P/B value of 0.7. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items